UK markets open in 6 hours 27 minutes

Interpace Diagnostics Group, Inc. (IDXG)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.3600-0.0500 (-3.55%)
At close: 03:26PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
802
802
-21,958
-14,943
-26,451
Depreciation & amortisation
1,601
1,601
3,502
5,374
5,501
Deferred income taxes
0
0
-93
38
37
Stock-based compensation
630
630
1,304
1,368
2,242
Change in working capital
-83
-83
-3,991
-1,131
5,227
Accounts receivable
49
49
-133
2,148
1,725
Accounts payable
489
489
-735
-1,817
-198
Other working capital
3,319
3,319
-8,014
-9,073
-15,554
Other non-cash items
839
839
1,147
715
60
Net cash provided by operating activities
3,789
3,789
-7,692
-8,719
-13,979
Cash flows from investing activities
Investments in property, plant and equipment
-470
-470
-322
-354
-1,575
Acquisitions, net
-
-
-
-
0
Net cash used for investing activities
-87
-87
6,206
-315
-1,575
Cash flows from financing activities
Debt repayment
-2,500
-2,500
0
-7,924
0
Common stock issued
0
0
108
335
434
Common stock repurchased
-32
-32
-108
0
-52
Other financing activities
-2,500
-2,500
-
-435
-
Net cash used provided by (used for) financing activities
-5,032
-5,032
3,000
8,976
16,605
Net change in cash
-1,330
-1,330
1,514
-58
1,051
Cash at beginning of period
4,828
4,828
3,314
3,372
2,321
Cash at end of period
3,498
3,498
4,828
3,314
3,372
Free cash flow
Operating cash flow
3,789
3,789
-7,692
-8,719
-13,979
Capital expenditure
-470
-470
-322
-354
-1,575
Free cash flow
3,319
3,319
-8,014
-9,073
-15,554